Skip to main content
Filing year 2024

ADVANCING CANCER TREATMENT

Moultonborough, New Hampshire·EIN 83-2886283·NTEE G12 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$43k
Total assets
$714k
Total expenses
$0
Reported officers
7
Mission

ACTS MISSION IS TO MAKE THE WASHINGTON, DC METROPOLITAN AREA A LEADER IN ADVANCING CLINICAL TRIAL ACCRUAL, THUS ACCELERATING IMPROVED CANCER CARE AND TREATMENT.

Reported officers (all unpaid)

No paid executives reported in 2024. ADVANCING CANCER TREATMENT reported 7 unpaid officers and board members on its 990.

Director
Vice President, Secretary
Director
Director
President, Treasurer
Director
Director
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.